CST3 and acute kidney injury: To address the issue of delayed AKI diagnosis when relying solely on SCr levels, Cystatin-C levels, and urine output, new biomarkers have been identified that can indicate kidney injury before it meets the KDIGO criteria for AKI, known as “subclinical AKI” [32] (Fig. 1).